IL137178A0 - Il-18 receptors - Google Patents
Il-18 receptorsInfo
- Publication number
- IL137178A0 IL137178A0 IL13717899A IL13717899A IL137178A0 IL 137178 A0 IL137178 A0 IL 137178A0 IL 13717899 A IL13717899 A IL 13717899A IL 13717899 A IL13717899 A IL 13717899A IL 137178 A0 IL137178 A0 IL 137178A0
- Authority
- IL
- Israel
- Prior art keywords
- receptor
- polypeptide
- receptors
- multimeric
- fragment
- Prior art date
Links
- 102000004557 Interleukin-18 Receptors Human genes 0.000 title abstract 2
- 108010017537 Interleukin-18 Receptors Proteins 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 abstract 1
- 101710138729 Interleukin-18 receptor accessory protein Proteins 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7230198P | 1998-01-23 | 1998-01-23 | |
| US7883598P | 1998-03-20 | 1998-03-20 | |
| US9446998P | 1998-07-28 | 1998-07-28 | |
| PCT/US1999/001419 WO1999037772A1 (en) | 1998-01-23 | 1999-01-22 | Il-18 receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL137178A0 true IL137178A0 (en) | 2001-07-24 |
Family
ID=27372056
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13717899A IL137178A0 (en) | 1998-01-23 | 1999-01-22 | Il-18 receptors |
| IL137178A IL137178A (en) | 1998-01-23 | 2000-07-05 | Il-18 receptors |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL137178A IL137178A (en) | 1998-01-23 | 2000-07-05 | Il-18 receptors |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US6589764B1 (de) |
| EP (1) | EP1047781B1 (de) |
| JP (1) | JP4271850B2 (de) |
| AT (1) | ATE272114T1 (de) |
| AU (1) | AU737592B2 (de) |
| CA (1) | CA2318482C (de) |
| DE (1) | DE69918946T2 (de) |
| DK (1) | DK1047781T3 (de) |
| ES (1) | ES2226335T3 (de) |
| IL (2) | IL137178A0 (de) |
| NZ (1) | NZ505880A (de) |
| PT (1) | PT1047781E (de) |
| WO (1) | WO1999037772A1 (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6326472B1 (en) | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
| US6472179B2 (en) * | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| US7083949B2 (en) | 1998-09-25 | 2006-08-01 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US20020155526A1 (en) | 1998-09-30 | 2002-10-24 | Busfield Samantha J. | Novel secreted immunomodulatory proteins and uses thereof |
| JP4741139B2 (ja) | 1999-12-23 | 2011-08-03 | ザイモジェネティクス, インコーポレイテッド | 可溶性インターロイキン−20レセプター |
| US7122632B2 (en) | 1999-12-23 | 2006-10-17 | Zymogenetics, Inc. | Soluble Interleukin-20 receptor |
| US6610286B2 (en) | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
| JP2004500086A (ja) * | 2000-02-10 | 2004-01-08 | アボット・ラボラトリーズ | ヒトインターロイキン18に結合する抗体とその調整方法および使用方法 |
| US20020025317A1 (en) * | 2000-07-20 | 2002-02-28 | Schering Ag | Bispecific monoclonal antibodies to IL-12 and IL-18 |
| US20020052475A1 (en) * | 2000-07-20 | 2002-05-02 | Schering Ag | High affinity soluble interleukin-18 receptor |
| EP1337636B1 (de) | 2000-08-08 | 2006-10-18 | ZymoGenetics, Inc. | Lösliche zcyctor 11 cytokinrezeptoren |
| DE60121808T2 (de) | 2000-09-15 | 2007-03-29 | Zymogenetics, Inc., Seattle | Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen |
| AU2002211744B8 (en) * | 2000-10-11 | 2008-03-20 | Viron Therapeutics, Inc. | Nucleic acid molecules and polypeptides for immune modulation |
| US7718368B2 (en) * | 2000-12-04 | 2010-05-18 | Viron Therapeutics Inc. | Immunomodulatory protein and useful embodiments thereof |
| GB2375604A (en) * | 2001-05-18 | 2002-11-20 | Warner Lambert Co | Methods for screening using interleukin soluble trimolecular complex |
| DK2270052T3 (en) | 2001-06-26 | 2018-07-02 | Amgen Inc | Antibodies to OPGL |
| EP1293566A1 (de) | 2001-09-17 | 2003-03-19 | Societe Des Produits Nestle S.A. | Ein löslicher Toll-ähnlicher Rezeptor |
| WO2003051384A1 (en) | 2001-12-17 | 2003-06-26 | Zymogenetics, Inc. | Method for treating cervical cancer |
| JP2006508056A (ja) | 2002-08-28 | 2006-03-09 | イミュネックス・コーポレーション | 心臓血管疾患を治療するための組成物および方法 |
| WO2004032837A2 (en) | 2002-10-08 | 2004-04-22 | Ares Trading S.A. | The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine |
| KR20050116392A (ko) | 2003-03-24 | 2005-12-12 | 지모제넥틱스, 인코포레이티드 | 항-il-22ra 항체 및 결합 파트너 및 염증에 있어서의사용 방법 |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| US7968684B2 (en) * | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
| US20050100965A1 (en) | 2003-11-12 | 2005-05-12 | Tariq Ghayur | IL-18 binding proteins |
| US7393684B2 (en) | 2003-11-21 | 2008-07-01 | Zymogenetics, Inc. | Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies |
| US7141382B1 (en) | 2004-10-12 | 2006-11-28 | Parikh Chirag R | Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality |
| BRPI0516975A (pt) | 2004-10-22 | 2008-09-30 | Zymogenetics Inc | anticorpo ou seu fragmento de ligação a antìgeno, composição farmacêutica, imunoconjugado, hibridoma, anticorpo monoclonal, e, uso de um anticorpo ou seu fragmento de ligação a antìgeno |
| EP1861423A4 (de) * | 2005-02-15 | 2010-01-27 | Apollo Life Sciences Ltd | Moleküle und chimere moleküle davon |
| EP1987061A1 (de) * | 2006-02-22 | 2008-11-05 | University of Zurich | Lösliche rezeptoren und verfahren zur behandlung von autoimmun- oder demyelinierenden krankheiten |
| WO2007147898A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Soluble heterodimeric receptors and uses thereof |
| CN101802197A (zh) * | 2007-05-14 | 2010-08-11 | 比奥根艾迪克Ma公司 | 单链FC(ScFc)区、包含其的结合多肽及与其相关的方法 |
| CL2008002153A1 (es) | 2007-07-24 | 2009-06-05 | Amgen Inc | Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r. |
| BR112012021576A2 (pt) | 2010-02-26 | 2016-10-25 | Novo Nordisk As | composições estáveis contendo anticorpo. |
| US20130136733A1 (en) | 2010-05-28 | 2013-05-30 | Novo Nordisk A/S | Stable Multi-Dose Compositions Comprising an Antibody and a Preservative |
| AU2011274423B2 (en) * | 2010-07-09 | 2016-02-11 | Bioverativ Therapeutics Inc. | Chimeric clotting factors |
| CA2805054A1 (en) | 2010-08-25 | 2012-03-01 | F. Hoffmann-La Roche Ag | Antibodies against il-18r1 and uses thereof |
| JOP20200308A1 (ar) | 2012-09-07 | 2017-06-16 | Novartis Ag | جزيئات إرتباط il-18 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989004838A1 (en) | 1987-11-25 | 1989-06-01 | Immunex Corporation | Interleukin-1 receptors |
| EP0533006A1 (de) * | 1991-09-18 | 1993-03-24 | F.Hoffmann-La Roche & Co. Aktiengesellschaft | Chimäre Interleukin 5-Rezeptor/Immunoglobulin-Polypeptide |
| US5470952A (en) | 1993-10-20 | 1995-11-28 | Regeneron Pharmaceuticals, Inc. | CNTF and IL-6 antagonists |
| WO1996013593A2 (en) * | 1994-10-26 | 1996-05-09 | Procept, Inc. | Soluble single chain t cell receptors |
| US5853721A (en) | 1995-01-31 | 1998-12-29 | Hoffmann-La Roche Inc. | Antibody to interleukin-12 receptor |
| DK1243597T3 (da) * | 1995-08-01 | 2008-09-22 | Hoffmann La Roche | Receptorer for det humane interleukin-12 |
| US5776731A (en) | 1996-02-21 | 1998-07-07 | Immunex Corporation | DNA encoding type-I interleukin-I receptor-like protein designated 2F1 |
| US7141393B2 (en) | 1996-12-26 | 2006-11-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18-receptor proteins |
| US6087116A (en) | 1997-03-12 | 2000-07-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18 (IL-18) receptor polypeptides and their uses |
| US6326472B1 (en) | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
| US6280955B1 (en) * | 1997-12-16 | 2001-08-28 | Tularik Inc. | Interleukin-1 receptor accessory proteins, nucleic acids and methods |
| US6472179B2 (en) | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| US20020052475A1 (en) | 2000-07-20 | 2002-05-02 | Schering Ag | High affinity soluble interleukin-18 receptor |
-
1999
- 1999-01-22 JP JP2000528679A patent/JP4271850B2/ja not_active Expired - Fee Related
- 1999-01-22 IL IL13717899A patent/IL137178A0/xx active IP Right Grant
- 1999-01-22 PT PT99904222T patent/PT1047781E/pt unknown
- 1999-01-22 AT AT99904222T patent/ATE272114T1/de active
- 1999-01-22 WO PCT/US1999/001419 patent/WO1999037772A1/en not_active Ceased
- 1999-01-22 NZ NZ505880A patent/NZ505880A/xx not_active IP Right Cessation
- 1999-01-22 DE DE69918946T patent/DE69918946T2/de not_active Expired - Lifetime
- 1999-01-22 DK DK99904222T patent/DK1047781T3/da active
- 1999-01-22 ES ES99904222T patent/ES2226335T3/es not_active Expired - Lifetime
- 1999-01-22 CA CA2318482A patent/CA2318482C/en not_active Expired - Fee Related
- 1999-01-22 AU AU24668/99A patent/AU737592B2/en not_active Ceased
- 1999-01-22 EP EP99904222A patent/EP1047781B1/de not_active Expired - Lifetime
-
2000
- 2000-07-05 IL IL137178A patent/IL137178A/en not_active IP Right Cessation
- 2000-07-21 US US09/621,502 patent/US6589764B1/en not_active Expired - Fee Related
-
2003
- 2003-05-15 US US10/439,458 patent/US7169581B2/en not_active Expired - Fee Related
-
2007
- 2007-01-29 US US11/699,676 patent/US7704945B2/en not_active Expired - Fee Related
-
2010
- 2010-03-03 US US12/716,993 patent/US8053233B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT1047781E (pt) | 2004-11-30 |
| NZ505880A (en) | 2003-06-30 |
| IL137178A (en) | 2007-06-17 |
| US7704945B2 (en) | 2010-04-27 |
| US7169581B2 (en) | 2007-01-30 |
| CA2318482C (en) | 2010-04-13 |
| DK1047781T3 (da) | 2004-12-06 |
| WO1999037772A1 (en) | 1999-07-29 |
| AU2466899A (en) | 1999-08-09 |
| US20070135625A1 (en) | 2007-06-14 |
| DE69918946D1 (de) | 2004-09-02 |
| US20030199040A1 (en) | 2003-10-23 |
| ES2226335T3 (es) | 2005-03-16 |
| JP2002500886A (ja) | 2002-01-15 |
| US8053233B2 (en) | 2011-11-08 |
| DE69918946T2 (de) | 2005-07-28 |
| EP1047781B1 (de) | 2004-07-28 |
| US20100190211A1 (en) | 2010-07-29 |
| CA2318482A1 (en) | 1999-07-29 |
| JP4271850B2 (ja) | 2009-06-03 |
| US6589764B1 (en) | 2003-07-08 |
| AU737592B2 (en) | 2001-08-23 |
| EP1047781A1 (de) | 2000-11-02 |
| ATE272114T1 (de) | 2004-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL137178A0 (en) | Il-18 receptors | |
| ATE346869T1 (de) | Agonistische antikörper gegen tie2 | |
| AU9386398A (en) | Cysteine rich receptors: trail | |
| ATE314371T1 (de) | Spiro-indole als y5-rezeptor antagonisten | |
| GEP20105118B (en) | Anti-vegf antibodies | |
| EP1580271A3 (de) | Menschliche, an ein G-Protein gekoppelte Rezeptoren, ohne bekannten Liganden | |
| EP1958965A3 (de) | Agonisten-Antikörper für einen Muskrezeptor und deren therapeutische Anwendungen | |
| BR9407933A (pt) | Antagonistas de receptores de endotelina | |
| AU2003250402A1 (en) | Beta-sheet forming peptides and material made thereof | |
| DE69942981D1 (de) | Flt4 (vegfr-3) als ziel für tumornachweis (imaging) und antitumortherapie | |
| DE69709561D1 (de) | Östrogen-Rezeptor | |
| ZA969775B (en) | Endothelin receptor antagonists. | |
| ZA9810685B (en) | Thrombin receptor antagonists. | |
| AU4729699A (en) | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists | |
| EP0684823A4 (de) | Fibrinogenrezeptorantagonisten. | |
| DE59801230D1 (de) | Endothelin-rezeptorantagonisten zur bekämpfung von hyperlipidämie | |
| AU2001295412A1 (en) | A novel polypeptide, a human cytokine receptor 10.67 and the polynucleotide encoding the polypeptide | |
| AU1178100A (en) | Novel g protein-coupled receptor protein, its dna and ligand thereof | |
| BR0010843A (pt) | Antagonistas de receptores de il-8 | |
| ATE429496T1 (de) | Gpr54 'knock-out' säugetiere und screening- verfahren, die sie verwenden | |
| AU7485996A (en) | Neuropeptide y-y5 receptor | |
| EP0870198A4 (de) | Rekombinanter c140-rezeptor, seine agonsiten und antagonisten, und den rezeptor kodierende nukleinsäuren | |
| BR0010863A (pt) | Antagonistas de receptores de il-8 | |
| ZA966552B (en) | Endothelin receptor antagonists. | |
| AR002996A1 (es) | Isoxazolinas mejoradas antagonistas del receptore de fibrinogeno. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |